Skip to content

Individual Approach for Bowel Preparation Before Colonoscopy

A Prospective, Randomized, Single-blind Study Evaluating Individual Approach on Bowel Preparation Quality for Colonoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01476735
Enrollment
266
Registered
2011-11-22
Start date
2011-08-31
Completion date
2013-03-31
Last updated
2018-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyethylene Glycol Solution, Risk Factors Inadequate Preparation, Split-dose Bowel Preparation

Brief summary

This is a prospective, randomized, single-blind study designed to evaluate the influence of individual approach on bowel preparation quality for colonoscopy. The investigators compare split-dose polyethylene glycol solution (PEG, Fortrans, Beaufour Ipsen) to modified split-dose PEG regarding predictors of inadequate preparation for colonoscopy.

Detailed description

Up to 22% of patients are not good prepared for colonoscopy and it is caused of aborted procedures and increased costs. There are identified predictors of inadequate bowel preparation before colonoscopy, but we still don't know if an individual approach improve the quality of preparation.

Interventions

OTHERindividual preparation for colonoscopy

The volume of polyethylene glycol solution depends on risk factors presented in each patient. Time of administration of second dose will be confirmed according to the time of colonoscopy. In case of constipation an enema before colonoscopy will be administered. All patients will give educational booklet of preparation before colonoscopy

Sponsors

Maria Sklodowska-Curie National Research Institute of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* men and women more than 18 years of age undergoing colonoscopy for routine clinical indications * provided written informed consent

Exclusion criteria

* lack of written informed consent or inability to provide informed consent or refusal to consent to the study * pregnancy and breast feeding * known allergy to PEG or bisakodyl * presence of serious conditions such as severe cadiac, renal or metabolic diseases, major psychiatric illness or end-stage cancer disease requiring taking narcotic drugs * colonoscopy performed under conscious sedation

Design outcomes

Primary

MeasureTime frameDescription
the index of preparation quality for the whole colon24 hoursthe percentage of patients with adequate bowel preparation; adequate preparation is defined as excellent, good and fair, inadequate is defined as poor or unprepared colon according to the Ottawa bowel preparation scale

Secondary

MeasureTime frameDescription
compliance safety24 hoursnumber of patients with completion of preparation number of patients with side effects of preparation in each group

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026